Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 May;18(5):855-61.
doi: 10.1007/s10461-013-0651-5.

Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035)

Affiliations
Clinical Trial

Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035)

Pamina M Gorbach et al. AIDS Behav. 2014 May.

Abstract

Use of HIV prevention methods may vary for women by types of sexual partners. In a microbicide safety and effectiveness trial (HPTN 035) differences in adherence to a microbicide study gel were compared between women with new versus ongoing partnerships over time. 1,757 women in the three HPTN 035 trial's arms completed the Follow-up Partner Status (FPS) questionnaire at their last study visit. Women married at baseline were asked if they had the same husband, new husband or new partner. Unmarried women were asked if they had changed partners or married. Self-reported gel adherence during the last sex act was compared at each quarterly visit between women with ongoing versus new partners. High gel adherence was compared with low gel adherence (85-100 vs. <85 % of last vaginal sex acts reported with gel use, respectively) in multivariable models to assess associations with partner change. Overall 7 % of women (n = 123) reported a new partner and 41 % (51) of those reported a new husband. Median gel adherence was reported to be 100 % in women with ongoing partners and 75 % for women with new partners (p < 0.001). In women reporting no gel use in their last sex act, only 12.5 % of the women with a new partner and none of those with an ongoing partner reported using condoms (p < 0.001). Fewer women with new partners reported using both the gel and condom during the last sex act as compared to women with ongoing partners (median 50 vs. 71.4 %, p < 0.001). After adjusting for age, site, education level, and sexual frequency, women with ongoing partners were more likely to report high gel adherence than those with new partners (AOR 2.5, 95 % CI 1.6, 3.9). This pattern persisted when gel use over time was compared between women with new versus ongoing partners. In the HPTN 035 trial, women with new partners had higher HIV incidence and reported less gel use and higher condom use. Specific counseling and support are needed to help women use potential HIV prevention methods, including microbicides, when they are changing partners.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Partnership Status at Last Study Visit: Women in 035 Gel Arms. n=1,757

Similar articles

Cited by

References

    1. Woodsong C, Alleman P, Musara P, et al. Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe. AIDS and behavior. 2012 Apr;16(3):785–790. - PMC - PubMed
    1. Karim QA, Baxter C, Karim SA. Topical microbicides--what’s new? Journal of acquired immune deficiency syndromes. 2013 Jul;63(Suppl 2):S144–149. - PubMed
    1. Baeten J, Donnell D, Ndase P, et al. ARV PrEP for HIV-1 Prevention among Heterosexual Men and Women; 19th Conference on Retroviruses and Opportunistic Infections (CROI); Seattle. 2012.
    1. Van Damme L, Corneli A, Ahmed K, et al. The FEM-PrEP Trial of Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) among African Women; Paper presented at: Conference on Retroviruses and Opportunistic Infections (CROI); Seattle. Mar 5–8, 2012. 2012.
    1. Montgomery CM, Lees S, Stadler J, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–740. - PubMed

Publication types